St. Jude Medical pumps $40M into Spinal Modulation

06/10/2013 | Minneapolis/St. Paul Business Journal

St. Jude Medical has made a $40 million investment in Spinal Modulation, giving it an exclusive option to acquire the California device startup for up to $300 million, plus milestone fees. St. Jude also gained rights to market Spinal Modulation's Axium Neurostimulator System, a CE-marked device designed to treat chronic pain, outside the U.S.

View Full Article in:

Minneapolis/St. Paul Business Journal

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR